GlassScriptPhysician profile
Luis T Campos
NPI 1578524765
$41,106.72
in general payments reported to CMS, 2019-2025
94 companies · $3,773 in 2025
The $3,773 reported for 2025 was more than what 78% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $6,278 · 2021: $2,516 · 2022: $2,495 · 2023: $5,096 · 2024: $3,982 · 2025: $3,773.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Honoraria: $2,000 · Grant: $235 · Education: $98.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,517.03 |
| Honoraria | $2,000.00 |
| Grant | $235.20 |
| Education | $98.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $5,020.44 | 2019-2021 | |
| Abbvie INC. | $4,983.46 | 2019-2025 | |
| Mylan Institutional INC. | $4,615.88 | 2019-2021 | |
| Incyte Corporation | $2,875.68 | 2020-2025 | Jakafi, Monjuvi |
| Janssen Biotech, INC. | $2,335.64 | 2019-2025 | Tecvayli, Darzalex, Erleada |
| Novartis Pharmaceuticals Corporation | $2,059.27 | 2019-2025 | |
| Chromacode, INC | $2,000.00 | 2023 | |
| Ipsen Biopharmaceuticals, INC | $1,769.76 | 2020-2025 | Onivyde |
| E.R. Squibb & Sons, L.L.C. | $1,449.64 | 2019-2025 | Opdivo, Opdualag |
| Merck Sharp & Dohme LLC | $1,130.45 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Celgene Corporation | $939.63 | 2019-2025 | Pomalyst, Reblozyl, Opdualag |
| Pfizer INC. | $927.72 | 2019-2025 | |
| Amgen INC. | $900.65 | 2019-2023 | Vectibix, Nplate, Xgeva |
| Genzyme Corporation | $810.88 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $531.69 | 2019-2025 | Enhertu, Calquence, Imfinzi |
Show all 94 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $524.29 | 2019-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $484.90 | 2019-2023 | Imbruvica, Epkinly |
| Genentech USA, INC. | $474.76 | 2019-2025 | Tecentriq, Venclexta, Polivy |
| Takeda Pharmaceuticals U.S.A., INC. | $418.53 | 2019-2025 | Ninlaro, Hyqvia |
| Taiho Oncology, INC. | $375.76 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $322.49 | 2019-2024 | Darzalex, Tecvayli, Talvey |
| US Oncology Corporate, INC. | $315.10 | 2024-2025 | |
| Exelixis INC. | $302.12 | 2019-2025 | Cabometyx |
| Daiichi Sankyo INC. | $277.77 | 2019-2025 | Enhertu, Datroway, Vanflyta |
| Lilly USA, LLC | $277.35 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Beigene USA, INC. | $249.63 | 2021-2024 | Brukinsa |
| Springworks Therapeutics, INC. | $214.25 | 2024-2025 | Ogsiveo, Gomekli |
| Amerisourcebergen Drug Corporation | $204.46 | 2024 | |
| Morphosys, US INC. | $202.79 | 2021-2024 | Monjuvi |
| Seagen INC. | $193.59 | 2019-2020 | |
| Sobi, INC | $191.43 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $182.97 | 2020-2025 | |
| Astellas Pharma US INC | $172.38 | 2019-2025 | Xospata, Xtandi, Vyloy |
| Regeneron Healthcare Solutions, INC. | $169.99 | 2019-2025 | Libtayo, Lynozyfic |
| Pharmaessentia USA Corporation | $150.14 | 2024-2025 | Besremi |
| Rigel Pharmaceuticals, INC. | $144.41 | 2021-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Siemens Medical Solutions USA, INC. | $136.74 | 2023 | Truebeam |
| Adc Therapeutics America, INC. | $134.57 | 2022-2024 | |
| Tempus Ai, INC | $128.22 | 2024-2025 | Xt Cdx |
| Cti Biopharma Corp. | $121.23 | 2022-2023 | Vonjo |
| Tersera Therapeutics LLC | $108.94 | 2024-2025 | Xermelo, Zoladex |
| Blueprint Medicines Corporation | $104.23 | 2021-2025 | Ayvakit |
| Alexion Pharmaceuticals, INC. | $101.56 | 2022-2024 | Ultomiris |
| Pharmacosmos Therapeutics INC. | $98.18 | 2024-2025 | Monoferric |
| Clovis Oncology, INC. | $90.70 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.66 | 2019-2024 | Gilotrif |
| Puma Biotechnology, INC. | $73.71 | 2019-2025 | |
| Geron Corporation | $72.75 | 2025 | Rytelo |
| Array Biopharma INC | $71.94 | 2021-2025 | Braftovi, Mektovi, Lorbrena |
| Boston Scientific Corporation | $71.42 | 2022-2023 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Verastem, INC. | $71.31 | 2019-2020 | |
| Aveo Pharmaceuticals, INC. | $69.73 | 2025 | |
| Aurobindo Pharma USA, INC. | $67.97 | 2020 | |
| Fennec Pharmaceuticals, INC. | $66.52 | 2024-2025 | Fyarro, Pedmark |
| Glaxosmithkline, LLC. | $63.77 | 2021-2023 | Shingrix |
| Agios Pharmaceuticals, INC. | $61.58 | 2019-2021 | |
| Acrotech Biopharma INC. | $60.22 | 2021 | |
| Sirtex Medical INC | $55.10 | 2023-2025 | Sir-Spheres Microspheres |
| Jazz Pharmaceuticals INC. | $53.94 | 2019-2025 | |
| Gilead Sciences, INC. | $53.37 | 2021-2024 | |
| Beone Medicines USA, INC. | $52.79 | 2025 | Brukinsa |
| Adaptive Biotechnologies Corporation | $47.79 | 2022-2023 | Clonoseq |
| Spectrum Pharmaceuticals INC. | $43.54 | 2024-2025 | Rolvedon |
| Tesaro, INC. | $41.72 | 2019 | |
| Kyowa Kirin, INC. | $39.07 | 2020-2023 | Poteligeo |
| Servier Pharmaceuticals LLC | $38.57 | 2024-2025 | |
| Stemline Therapeutics INC. | $34.35 | 2022-2023 | Orserdu |
| Karyopharm Therapeutics INC. | $32.88 | 2025 | Xpovio |
| Mirati Therapeutics, INC. | $31.56 | 2023-2024 | Krazati |
| Kite Pharma, INC. | $29.83 | 2024 | Yescarta |
| Foundation Medicine, INC. | $26.28 | 2019 | |
| G1 Therapeutics, INC. | $24.69 | 2023 | Cosela |
| Myovant Sciences INC. | $24.65 | 2022 | |
| Syndax Pharmaceuticals, INC. | $24.46 | 2025 | |
| Urogen Pharma, INC. | $24.13 | 2024 | |
| Apellis Pharmaceuticals, INC. | $23.75 | 2023 | |
| Secura Bio, INC. | $23.25 | 2020 | |
| Fresenius Kabi USA, LLC | $23.20 | 2025 | |
| Acceleron Pharma, INC. | $23.13 | 2020 | |
| Verity Pharmaceuticals INC. | $22.91 | 2022 | |
| Emd Serono, INC. | $21.60 | 2022 | |
| Biocartis US, INC | $20.29 | 2019 | |
| Sumitomo Pharma America, INC. | $20.08 | 2023 | Orgovyx |
| Epizyme, INC. | $19.98 | 2022 | |
| Biocompatibles, INC. | $19.70 | 2019 | |
| Sandoz INC. | $19.66 | 2020 | |
| Immunogen, INC. | $18.94 | 2023 | Elahere |
| Emmaus Medical, INC. | $18.67 | 2021 | |
| Fortovia Therapeutics, INC. | $18.42 | 2020 | |
| Dova Pharmaceuticals | $16.24 | 2021 | |
| Eusa Pharma (US) LLC | $14.85 | 2020 | |
| Amneal Pharmaceuticals LLC | $14.76 | 2025 | Alymsys |
| Iovance Biotherapeutics, INC. | $14.74 | 2025 | Amtagvi |
| Pharmaand Gmbh | $8.98 | 2025 | Rubraca |
Drugs and devices associated with these payments
Keytruda $651Opdivo $530Enhertu $360Tecvayli $317Imbruvica $315Darzalex $313Lenvima $305Elahere $291Lynparza $281Pomalyst $277Tukysa $277Ibrance $270Opdualag $270Fabhalta $252Erleada $240Brukinsa $234Kisqali $234Cabometyx $218Reblozyl $193Rybrevant $183Sarclisa $173Talvey $172Akeega $161Ogsiveo $152Besremi $150Carvykti $138Truebeam $137Adcetris $131Elrexfio $131Padcev $130Vonjo $125Epkinly $124Ayvakit $123Jaypirca $119Xtandi $114Xt Cdx $113Calquence $106Monoferric $98.18Verzenio $97.85Ninlaro $97.29Tavalisse $90.45Rezlidhia $90.45Enjaymo $86.33Vitrakvi $84.06Stivarga $84.06Monjuvi $81.64Orgovyx $81.21Scemblix $80.26Venclexta $78.97Ultomiris $77.56Doptelet $72.92Welireg $72.85Rytelo $72.75Xermelo $71.48Fotivda $69.73Inqovi $66.67Lonsurf $66.67Tecentriq $65.51Libtayo $62.94Hyqvia $61.69Talzenna $61.13Imfinzi $59.84Keytruda Qlex $58.76Therasphere Y90 Glass Microspheres 10 Gbq $58.65Onivyde $58.10Promacta $57.46Braftovi $57.15Mektovi $57.15Sir-Spheres Microspheres $55.10Lynozyfic $53.73Wayrilz $51.76Inlyta $47.53Retevmo $47.38Fyarro $47.01Lutathera $46.04Rolvedon $43.54Pluvicto $43.10Xospata $41.52Gomekli $40.89Jakafi $40.83Bosulif $40.76Synagis $40.08Vectibix $39.99Nplate $39.99Zoladex $37.46Nubeqa $37.42Datroway $36.40Xpovio $32.88Lorbrena $32.56Clonoseq $31.85Krazati $31.56Yescarta $29.83Ziihera $29.55Tabrecta $27.73Xgeva $26.36Jevtana $25.35Cosela $24.69Jelmyto $24.13Gilotrif $23.18Mekinist $22.68
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Campos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.